Skip to main content

Current Understanding and Persistent Questions About the Pathogenesis and Presentation of Epidemic Kaposi Sarcoma

  • Living reference work entry
  • First Online:
  • 176 Accesses

Definition

Kaposi sarcoma (KS) is a vascular neoplasm caused by infection with human herpesvirus 8 (HHV-8, also known as Kaposi sarcoma-associated herpesvirus) which may involve the skin, mucous membranes or viscera. Epidemic KS is the form of the disease found among persons with HIV infection; it is the most common malignancy in persons with HIV worldwide.

Introduction

Kaposi sarcoma (KS) remains among the most common cancers seen in persons with human immunodeficiency virus (HIV) infection more than three decades after it was initially described as a key-presenting manifestation of the acquired immunodeficiency syndrome (AIDS) in 1981. While new cases of KS have decreased dramatically in the United States with the widespread availability of combination antiretroviral therapy (cART), the incidence remains threefold higher than prior to the HIV pandemic, and the cancer (Cancers Related to HIV) is the most common in the entire male population of several countries in sub-Saharan Africa....

This is a preview of subscription content, log in via an institution.

References

  • Achenbach CJ, Cole SR, et al. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS. 2011;25(5):691–700.

    Article  PubMed  Google Scholar 

  • Achenbach CJ, Harrington RD, et al. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis. 2012;54(3):424–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Aoki Y, Tosato G. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood. 2004;104(3):810–4.

    Article  CAS  PubMed  Google Scholar 

  • Biggar RJ, Chaturvedi AK, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962–72.

    Article  PubMed  Google Scholar 

  • Bihl F, Berger C, et al. Cellular immune responses and disease control in acute AIDS-associated Kaposi’s sarcoma. AIDS. 2009;23(14):1918–22.

    Article  PubMed  Google Scholar 

  • Casper C, Redman M, et al. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr. 2004;35(3):233–8.

    Article  PubMed  Google Scholar 

  • Chang Y, Cesarman E, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.

    Article  CAS  PubMed  Google Scholar 

  • Dollard SC, Butler LM, et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the “Kaposi’s sarcoma belt”. Int J Cancer. 2010;127(10):2395–401.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Engels EA, Biggar RJ, et al. Detection and quantification of Kaposi’s sarcoma-associated herpesvirus to predict AIDS-associated Kaposi’s sarcoma. AIDS. 2003;17(12):1847–51.

    Article  PubMed  Google Scholar 

  • Gantt S, Kakuru A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54(5):670–4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Gondos A, Brenner H, et al. Cancer survival in Kampala, Uganda. Br J Cancer. 2005;92(9):1808–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gregory SM, West JA, et al. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A. 2009;106(28):11725–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grulich AE, van Leeuwen MT, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.

    Article  PubMed  Google Scholar 

  • Johnston C, Orem J, et al. Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One. 2009;4(1):e4222.

    Article  PubMed Central  PubMed  Google Scholar 

  • Krown SE, Testa MA, et al. AIDS-related Kaposi’s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997;15(9):3085–92.

    CAS  PubMed  Google Scholar 

  • Martin JN, Ganem DE, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338(14):948–54.

    Article  CAS  PubMed  Google Scholar 

  • Martin J, Laker M, et al. Kaposi’s sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation. Infect Agent Cancer. 2009;4 Suppl 2:17.

    Article  Google Scholar 

  • Nasti G, Martellotta F, et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer. 2003;98(11):2440–6.

    Article  PubMed  Google Scholar 

  • Nguyen HQ, Magaret AS, et al. Persistent Kaposi sarcoma in the era of HAART: characterizing the predictors of clinical response. AIDS. 2008;22(8):937–45.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pauk J, Huang ML, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343(19):1369–77.

    Article  CAS  PubMed  Google Scholar 

  • Ribechini E, Fortini C, et al. Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8. J Immunol. 2006;176(2):923–30.

    Article  CAS  PubMed  Google Scholar 

  • Sabbah S, Jagne YJ, et al. T-cell immunity to Kaposi sarcoma‚ Äìassociated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells. Blood. 2012;119(9):2083–92.

    Article  CAS  PubMed  Google Scholar 

  • Uldrick TS, Wang V, et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis. 2010;51(3):350–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vieira J, O’Hearn P, et al. Activation of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol. 2001;75(3):1378–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zong J, Ciufo DM, et al. Genotypic analysis at multiple loci across Kaposi’s sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol. 2002;23(3):119–48.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Corey Casper M.D., MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Casper, C. (2013). Current Understanding and Persistent Questions About the Pathogenesis and Presentation of Epidemic Kaposi Sarcoma. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_19-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_19-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics